Marc Abrams, PhDVice President, Discovery Research at Dicerna Pharmaceuticals
As a Senior Research Director at Dicerna, I lead pipeline programs for specific targets/indications and support optimization of our RNAi technology platforms. I joined Dicerna in 2014 after 16 years at Merck and Co., Inc, where I held positions of increasing responsibility from Staff Biochemist through Associate Director. During that tenure, I worked as a biologist and pharmacologist on discovery programs across different modalities (small molecule and nucleic acid therapeutics) in oncology, virology and immunology. I hold a Ph.D. in Biochemistry from Thomas Jefferson University, where I studied under antisense pioneer Dr. Eric Wickstrom, and have authored or co-authored over 30 peer-reviewed publications.